Veradigm Inc. (NASDAQ:MDRX) Given Average Rating of “Hold” by Brokerages

Shares of Veradigm Inc. (NASDAQ:MDRX) have been given a consensus recommendation of “Hold” by the five analysts that are currently covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $11.25.

Several equities research analysts have weighed in on MDRX shares. Barclays started coverage on Veradigm in a research note on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 price objective on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $10.00 price objective (down from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Royal Bank of Canada reduced their price objective on Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research note on Friday, January 19th. Finally, StockNews.com began coverage on Veradigm in a research report on Sunday, April 7th. They set a “hold” rating for the company.

Veradigm Price Performance

Shares of NASDAQ MDRX opened at $7.80 on Friday. The business’s 50 day moving average is $7.96 and its two-hundred day moving average is $10.36. Veradigm has a 1-year low of $5.01 and a 1-year high of $14.09.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Quarry LP purchased a new position in shares of Veradigm during the first quarter valued at approximately $37,000. TFO Wealth Partners LLC boosted its holdings in shares of Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after purchasing an additional 5,264 shares during the period. Gladius Capital Management LP boosted its holdings in shares of Veradigm by 135.0% in the fourth quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock valued at $66,000 after purchasing an additional 3,587 shares during the period. Tower Research Capital LLC TRC boosted its holdings in shares of Veradigm by 95.0% in the second quarter. Tower Research Capital LLC TRC now owns 5,310 shares of the software maker’s stock valued at $67,000 after purchasing an additional 2,587 shares during the period. Finally, Envestnet Asset Management Inc. boosted its holdings in shares of Veradigm by 27.4% in the first quarter. Envestnet Asset Management Inc. now owns 32,691 shares of the software maker’s stock valued at $69,000 after purchasing an additional 7,027 shares during the period.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.